Ganymed Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人:
Sahin, Ugur,Türeci, Özlem,Mitnacht-Kraus, Rita,Jacobs, Stefan Denis,Utsch, Magdalena Jadwiga,Heinz, Cornelia Adriana Maria,Stadler, Christiane Regina
申请号：
HRP20171218
公开号：
HRP20171218T1
申请日:
2017.08.08
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
